-
Optimi To Supply Psilocybin For New Zealand's Mātai Medical Research Institute
Tuesday, April 9, 2024 - 3:25pm | 610Canadian licensed psychedelics pharmaceutical manufacturer Optimi Health Corp. (OTCQX:OPTHF) has signed an international agreement to supply natural psilocybin to New Zealand-based Mātai Medical Research Institute, on behalf of the Tū Wairua Project. The agreement marks Optimi’s first...